1 |
Seo HG. Screening for early detection of cancers II. J Korean Med Assoc 2006;49(6):515-530 (Korean).
DOI
|
2 |
Walter SD, Day NE. Estimation of the duration of a pre-clinical disease state using screening data. Am J Epidemiol 1983;118(6):865-886.
DOI
|
3 |
Draisma G, van Rosmalen J. A note on the catch-up time method for estimating lead or sojourn time in prostate cancer screening. Stat Med 2013;32(19):3332-3341.
DOI
|
4 |
Pashayan N, Duffy SW, Pharoah P, Greenberg D, Donovan J, Martin RM, et al. Mean sojourn time, overdiagnosis, and reduction in advanced stage prostate cancer due to screening with PSA: implications of sojourn time on screening. Br J Cancer 2009;100(7):1198-1204.
DOI
|
5 |
Chen TH, Kuo HS, Yen MF, Lai MS, Tabar L, Duffy SW. Estimation of sojourn time in chronic disease screening without data on interval cases. Biometrics 2000;56(1):167-172.
DOI
|
6 |
Yoo SH, Lee J, Lee K, Lee I, Bae JM. Ethical principles and practice guidelines concerning the usage of public database for medical researches. J Korean Med Assoc 2013;56(11):1031-1038 (Korean).
DOI
ScienceOn
|
7 |
American Cancer Society. Diagnosis of stomach cancer: biopsy [cited 2014 Mar 13] Available from: http://www.cancer.org/cancer/stomachcancer/detailedguide/stomach-cancer-diagnosis.
|
8 |
Korea Central Cancer Registry. Annual report of cancer statistics in Korea in 2010 [cited 2014 Mar 13]. Available from: http://ncc.re.kr/manage/manage03_033_view.jsp?bbsnum=250&hSelSearch=&hTxtKeyword=¤t_page=1&cd=null (Korean).
|
9 |
Korea Medical Institute. KMI nationwide network [cited 2014 Feb 10]. Available from: http://www.kmi.or.kr/kor/center/network/kmi.web (Korean).
|
10 |
Korea National Institute of Health. Clinical Research Information Service [cited 2014 Mar 13]. Available from: https://cris.nih.go.kr/cris/index.jsp (Korean).
|
11 |
National Cancer Center. National Cancer Screening Program [cited 2014 Mar 13]. Available from: http://ncc.re.kr/english/programs/progarms03.jsp.
|
12 |
Smith RA. Breast cancer screening among women younger than age 50: a current assessment of the issues. CA Cancer J Clin 2000;50(5):312-336.
DOI
|
13 |
Duffy SW, Chen HH, Tabar L, Day NE. Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase. Stat Med 1995;14(14):1531-1543.
DOI
|
14 |
Gemignani ML. Breast cancer screening: why, when, and how many? Clin Obstet Gynecol 2011;54(1):125-132.
DOI
|
15 |
Brenner H, Altenhofen L, Katalinic A, Lansdorp-Vogelaar I, Hoffmeister M. Sojourn time of preclinical colorectal cancer by sex and age: estimates from the German national screening colonoscopy database. Am J Epidemiol 2011;174(10):1140-1146.
DOI
|